Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diwei Zheng

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
International Immunopharmacology|June 10, 2023
The onco-embryonic antigen ROR1 is a target of chimeric antigen T cells for colorectal cancerShangsen Meng, Ming Li, Le Qin, et al.
Cell Reports. Medicine|August 29, 2025
Selenized neural stem cell-derived exosomes: A neotype therapeutic agent for traumatic injuries of the central nervous systemWenjing Wang, Guihong Lu, Peilin Guo, et al.
Molecular Therapy Oncolytics|January 19, 2023
Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levelsJiang Lv, Le Qin, Ruocong Zhao, et al.
Science Immunology|March 21, 2025
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activityYao Li, Jiongliang Wang, Linfu Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 8, 2025
RELA Ablation Contributes to Progression of Hepatocellular Carcinoma with TP53<sup>R249S</sup> Mutation and is a Potential Therapeutic TargetZhiping Wu, Zhe Wang, Diwei Zheng, et al.
Cell Host & Microbe|August 28, 2024
Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasisPeilin Guo, Wenjing Wang, Qian Xiang, et al.
Oncogene|January 16, 2021
Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cellsShouheng Lin, Xuchao Zhang, Guohua Huang, et al.
Frontiers in Immunology|June 13, 2022
The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell MalignanciesDiwei Zheng, Xindong Wang, Lin Cheng, et al.
Molecular Therapy Oncolytics|July 5, 2022
DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2DShanglin Li, Ruocong Zhao, Diwei Zheng, et al.
Cell Reports. Medicine|March 19, 2025
CD4<sup>+</sup> anti-TGF-β CAR T cells and CD8<sup>+</sup> conventional CAR T cells exhibit synergistic antitumor effectsDiwei Zheng, Le Qin, Jiang Lv, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
International Immunopharmacology|June 10, 2023
The onco-embryonic antigen ROR1 is a target of chimeric antigen T cells for colorectal cancerShangsen Meng, Ming Li, Le Qin, et al.
Cell Reports. Medicine|August 29, 2025
Selenized neural stem cell-derived exosomes: A neotype therapeutic agent for traumatic injuries of the central nervous systemWenjing Wang, Guihong Lu, Peilin Guo, et al.
Molecular Therapy Oncolytics|January 19, 2023
Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levelsJiang Lv, Le Qin, Ruocong Zhao, et al.
Science Immunology|March 21, 2025
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activityYao Li, Jiongliang Wang, Linfu Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 8, 2025
RELA Ablation Contributes to Progression of Hepatocellular Carcinoma with TP53<sup>R249S</sup> Mutation and is a Potential Therapeutic TargetZhiping Wu, Zhe Wang, Diwei Zheng, et al.
Cell Host & Microbe|August 28, 2024
Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasisPeilin Guo, Wenjing Wang, Qian Xiang, et al.
Oncogene|January 16, 2021
Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cellsShouheng Lin, Xuchao Zhang, Guohua Huang, et al.
Frontiers in Immunology|June 13, 2022
The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell MalignanciesDiwei Zheng, Xindong Wang, Lin Cheng, et al.
Molecular Therapy Oncolytics|July 5, 2022
DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2DShanglin Li, Ruocong Zhao, Diwei Zheng, et al.
Cell Reports. Medicine|March 19, 2025
CD4<sup>+</sup> anti-TGF-β CAR T cells and CD8<sup>+</sup> conventional CAR T cells exhibit synergistic antitumor effectsDiwei Zheng, Le Qin, Jiang Lv, et al.
Pageof 5